Shanghai Rightongene Biotechnology Co., Ltd. (SHA:688217)
China
· Delayed Price · Currency is CNY 29.55
-0.62 (-2.06%)
At close: Mar 9, 2026
SHA:688217 Market Cap
SHA:688217 has a market cap or net worth of 1.71 billion as of March 10, 2026. Its market cap has increased by 40.60% in one year.
Market Cap
1.71B
Enterprise Value
1.50B
Revenue
174.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
29.55
Market Cap Chart
Since May 17, 2021, SHA:688217's market cap has decreased from 5.91B to 1.71B, a decrease of -71.11%. That is a compound annual growth rate of -22.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 1.63B | 12.14% |
| Dec 31, 2025 | 1.45B | 42.90% |
| Dec 31, 2024 | 1.02B | -49.08% |
| Dec 29, 2023 | 2.00B | 1.72% |
| Dec 30, 2022 | 1.96B | -51.39% |
| Dec 31, 2021 | 4.04B | -31.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tiansheng Pharmaceutical Group | 1.75B |
| Sailong Pharmaceutical Group | 1.94B |
| Hunan Nucien Pharmaceutical | 2.22B |
| Jiangsu Gdk Biological Technology | 2.36B |
| Hubei Goto Biopharm | 2.39B |
| Guiyang Xintian Pharmaceutical | 2.45B |
| Jiangsu CoWin Biotech | 2.54B |
| Zhejiang East Asia Pharmaceutical | 2.58B |